Publication | Closed Access

Oral Coenzyme Q10 Supplementation in Patients with Nonalcoholic Fatty Liver Disease: Effects on Serum Vaspin, Chemerin, Pentraxin 3, Insulin Resistance and Oxidative Stress

ObesityMetabolic SyndromeMetabolic Associated SteatohepatitisHepatologyMetabolic Associated Steatotic Liver DiseaseNonalcoholic Fatty Liver DiseaseSerum VaspinLiver PhysiologyPentraxin 3HepatotoxicityLiver DiseaseFatty Liver DiseaseMetabolismMedicineOxidative StressHealth Sciences